Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29501 - 29525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	CST7	8530	upregulated	decitabine results in increased expression of CST7 mRNA	20p11.21	A21919 A20985
Decitabine	Approved Investigational	CTAG1B	1485	upregulated	decitabine results in increased expression of CTAG1B mRNA	Xq28	A21957 A21955
Decitabine	Approved Investigational	CTAG2	30848	upregulated	decitabine results in increased expression of CTAG2 mRNA	Xq28	A21955
Decitabine	Approved Investigational	CTCFL	140690	upregulated	decitabine results in increased expression of CTCFL mRNA	20q13.31	A21915
Decitabine	Approved Investigational	CTGF	1490	upregulated	decitabine results in increased expression of CTGF mRNA	6q23.2	A21915
Decitabine	Approved Investigational	CTSH	1512	upregulated	decitabine results in increased expression of CTSH mRNA	15q25.1	A20985
Decitabine	Approved Investigational	CTSL	1514	upregulated	decitabine results in increased expression of CTSL mRNA	9q21.33	A21919
Decitabine	Approved Investigational	CXCL12	6387	upregulated	decitabine results in increased expression of CXCL12 mRNA	10q11.21	A21958 A21959
Decitabine	Approved Investigational	CXCL14	9547	upregulated	decitabine results in increased expression of CXCL14 mRNA	5q31.1	A21959
Decitabine	Approved Investigational	CXCL5	6374	upregulated	decitabine results in increased expression of CXCL5 mRNA	4q13.3	A21959
Decitabine	Approved Investigational	CXCL8	3576	upregulated	decitabine results in increased expression of CXCL8 mRNA	4q13.3	A21915
Decitabine	Approved Investigational	CYGB	114757	upregulated	decitabine results in increased expression of CYGB mRNA	17q25.1	A21960
Decitabine	Approved Investigational	CYP1A1	1543	upregulated	decitabine results in increased expression of CYP1A1 mRNA	15q24.1	A21918
Decitabine	Approved Investigational	CYP1A2	1544	upregulated	decitabine results in increased expression of CYP1A2 mRNA	15q24.1	A21961
Decitabine	Approved Investigational	DAPK1	1612	upregulated	decitabine results in increased expression of DAPK1 mRNA	9q21.33	A21962 A21931 A21963
Decitabine	Approved Investigational	DAPK2	23604	upregulated	decitabine results in increased expression of DAPK2 mRNA	15q22.31	A21931
Decitabine	Approved Investigational	DAPK3	1613	upregulated	decitabine results in increased expression of DAPK3 mRNA	19p13.3	A21931
Decitabine	Approved Investigational	DAZL	1618	upregulated	decitabine results in increased expression of DAZL mRNA	3p24.3	A20985 A21915
Decitabine	Approved Investigational	DCC	1630	upregulated	decitabine results in increased expression of DCC mRNA	18q21.2	A21964
Decitabine	Approved Investigational	DCHS1	8642	upregulated	decitabine results in increased expression of DCHS1 mRNA	11p15.4	A20985
Decitabine	Approved Investigational	DHRS9	10170	upregulated	decitabine results in increased expression of DHRS9 mRNA	2q31.1	A20985
Decitabine	Approved Investigational	DIP2C	22982	upregulated	decitabine results in increased expression of DIP2C mRNA	10p15.3	A20985
Decitabine	Approved Investigational	DKK1	22943	upregulated	decitabine results in increased expression of DKK1 mRNA	10q21.1	A21930 A21936
Decitabine	Approved Investigational	DLK1	8788	upregulated	decitabine results in increased expression of DLK1 mRNA	14q32.2	A20985
Decitabine	Approved Investigational	DLX2	1746	upregulated	decitabine results in increased expression of DLX2 mRNA	2q31.1	A21915

Displaying entries 29501 - 29525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability